Cenovus Energy Inc vs Tenet Healthcare Corporation — how do they compare? Cenovus Energy Inc trades at $31.38 (market cap $57.90B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Cenovus Energy Inc is far larger — about 2.8× Tenet Healthcare Corporation's market cap, and Cenovus Energy Inc pays a 1.97% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Tenet Healthcare Corporation for 15 Days on average.
| CVE | THC | |
|---|---|---|
Market Cap | $57.90B | $20.92B |
Volume | 7,863,588 | 455,764 |
Sector | Energy | Health |
52-Week High | $33.92 | $280.77 |
52-Week Low | $15.85 | $161.37 |
Typical Hold Time | 46 Days | 15 Days |
Enterprise Value | $63.84B | $32.00B |
Dividend Yield | 1.97% | — |
Signals from Pluang's Aura AI — not financial advice
Cenovus Energy (CVE) trades at $30.63, down 1.95% on the day, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 12.14, EV/EBITDA of 6.03, and robust profitability metrics including 20.96% ROE. Recent analyst coverage shows 40.74% buy ratings, while technical indicators point to support near $30 with resistance at $31-32 levels. Cash flow trends indicate operational strength with $8.23B from operations in 2025.
CVE presents a mixed outlook with attractive valuation metrics and strong profitability offset by bearish technical signals. The company's projected 2026 revenue growth to $58B and net income of $6.7B suggests upside potential, though energy sector volatility and recent price weakness near key support levels warrant caution. Analyst consensus leans positive with limited sell-side coverage.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →